3-Chloro-PCP

3-Chloro-PCP (3-Cl-PCP) is a dissociative anesthetic that belongs to the class of chemical compounds known as arylcyclohexylamines. Arylcyclohexylamines are known for their ability to produce dissociation of the mind from the body (dissociative anesthesia) and have been used in both medical and recreational contexts. 3-Chloro-PCP is closely related to more widely known substances such as phencyclidine (PCP) and ketamine, differing primarily in its chemical structure through the substitution of a chlorine atom.
Chemistry[edit]
3-Chloro-PCP is a derivative of phencyclidine and features a chlorine atom substituted at the 3-position of the phenyl ring. This modification significantly affects its pharmacological properties. The compound belongs to the arylcyclohexylamine class, which is characterized by a cyclohexylamine unit with an aryl group attached. The presence of the chlorine atom in 3-Chloro-PCP may influence its lipophilicity, potency, and affinity for various receptors in the brain, particularly the N-methyl-D-aspartate (NMDA) receptor, which is implicated in its dissociative effects.
Pharmacology[edit]
The primary mechanism of action of 3-Chloro-PCP, like other dissociative anesthetics, involves antagonism of the NMDA receptor. By inhibiting the activity of this receptor, 3-Chloro-PCP disrupts the normal neurotransmission processes, leading to dissociation, analgesia, and anesthesia. The alteration in perception, mood, and consciousness associated with 3-Chloro-PCP is primarily due to its impact on the glutamatergic system, although it may also interact with other neurotransmitter systems.
Effects[edit]
Users of 3-Chloro-PCP may experience a range of effects, from mild dissociation and altered sensory perception to profound anesthesia and loss of consciousness. The intensity of the effects can vary based on the dose, route of administration, individual sensitivity, and the presence of other substances. Commonly reported effects include euphoria, detachment from self or environment, altered perception of time and space, and in higher doses, complete dissociative anesthesia.
Safety and Legality[edit]
The safety profile of 3-Chloro-PCP is not well-documented, and like other research chemicals, it may pose significant risks to health and well-being. Potential adverse effects can include confusion, agitation, and harmful behavior towards oneself or others. The long-term effects of 3-Chloro-PCP use are unknown, and there is potential for abuse and dependence.
Legally, 3-Chloro-PCP falls into a gray area in many jurisdictions. It may be considered an analog of PCP and thus subject to control under analog acts or specific drug legislation. However, the legal status can vary significantly from one country to another, and it is essential to be aware of local laws regarding its possession, use, and distribution.
Conclusion[edit]
3-Chloro-PCP is a potent dissociative anesthetic with a chemical structure and mechanism of action similar to other arylcyclohexylamines. While it may offer unique effects for users seeking dissociative experiences, the lack of comprehensive research and potential for adverse outcomes necessitates caution. The legal and health risks associated with 3-Chloro-PCP underscore the importance of thorough understanding and regulation of novel psychoactive substances.
|
This article is a stub You can help WikiMD by registering and expanding it with useful details, internal links, formatting, and categories. Editing is available only to registered and verified users. WikiMD is a comprehensive, free health and wellness encyclopedia. |
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian